Lucid Diagnostics Inc.
LUCD
$1.01
$0.022.07%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 27.20% | -27.41% | -18.89% | -18.44% | -31.46% |
| Total Depreciation and Amortization | -1.58% | -25.28% | -43.77% | -55.65% | -62.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -93.94% | 189.25% | 127.61% | 85.96% | 190.26% |
| Change in Net Operating Assets | -28.47% | 36.67% | 67.65% | 74.64% | -600.57% |
| Cash from Operations | -4.84% | -5.31% | 1.06% | -0.48% | -14.84% |
| Capital Expenditure | 9.38% | 33.45% | -91.04% | -66.81% | -46.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Investing | 54.56% | 69.50% | 27.94% | -221.68% | -191.29% |
| Total Debt Issued | -100.00% | -98.33% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 223.59% | 12,908.65% | 12,908.20% | 4,904.91% | 2,300.63% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -100.00% | -49.78% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8.67% | 22.34% | 118.52% | 41.10% | 89.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 462.47% | 256.64% | 443.51% | 181.08% | 103.18% |